IDEAYA Biosciences, Inc. (IDYA)
35.36
+1.55
(+4.58%)
USD |
NASDAQ |
Oct 20, 16:00
35.36
0.00 (0.00%)
After-Hours: 20:00
IDEAYA Biosciences Research and Development Expense (TTM) : 374.01M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 374.01M |
| March 31, 2026 | 339.54M |
| December 31, 2025 | 314.70M |
| September 30, 2025 | 368.29M |
| June 30, 2025 | 342.45M |
| March 31, 2025 | 322.75M |
| December 31, 2024 | 294.67M |
| September 30, 2024 | 193.26M |
| June 30, 2024 | 169.81M |
| March 31, 2024 | 144.45M |
| December 31, 2023 | 129.51M |
| September 30, 2023 | 115.45M |
| June 30, 2023 | 104.12M |
| March 31, 2023 | 97.74M |
| December 31, 2022 | 89.54M |
| September 30, 2022 | 80.93M |
| Date | Value |
|---|---|
| June 30, 2022 | 74.06M |
| March 31, 2022 | 66.25M |
| December 31, 2021 | 58.16M |
| September 30, 2021 | 54.10M |
| June 30, 2021 | 48.62M |
| March 31, 2021 | 42.24M |
| December 31, 2020 | 39.70M |
| September 30, 2020 | 36.19M |
| June 30, 2020 | 35.09M |
| March 31, 2020 | 35.35M |
| December 31, 2019 | 34.32M |
| September 30, 2019 | 33.36M |
| June 30, 2019 | 36.97M |
| March 31, 2019 | 34.54M |
| December 31, 2018 | 31.75M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 86.86M |
| Xencor, Inc. | 255.76M |
| BioMarin Pharmaceutical, Inc. | 766.68M |
| MediciNova, Inc. | 5.357M |
| Viking Therapeutics, Inc. | 509.32M |